Medline Inc. Class A Common Stock (MDLN) — Capital Reinvestment Ratio
Medline Inc. Class A Common Stock (MDLN) has a Capital Reinvestment Ratio of 0.16x as of June 2026, meaning it reinvests 0% of its operating cash flow ($715.00 Million) in capital expenditures ($111.00 Million). Check MDLN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medline Inc. Class A Common Stock Capital Reinvestment Ratio (2022–2025)
This chart tracks Medline Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Medline Inc. Class A Common Stock operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Medline Inc. Class A Common Stock (2022–2025)
Year-by-year Capital Reinvestment Ratio for Medline Inc. Class A Common Stock from 2022 to 2025. See free cash flow generation of Medline Inc. Class A Common Stock to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $187.00 Million | $254.00 Million | — |